Susan E. Conrad

1.6k total citations
41 papers, 1.4k citations indexed

About

Susan E. Conrad is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Susan E. Conrad has authored 41 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 22 papers in Oncology and 10 papers in Genetics. Recurrent topics in Susan E. Conrad's work include Cancer-related Molecular Pathways (9 papers), Cytokine Signaling Pathways and Interactions (7 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Susan E. Conrad is often cited by papers focused on Cancer-related Molecular Pathways (9 papers), Cytokine Signaling Pathways and Interactions (7 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Susan E. Conrad collaborates with scholars based in United States, Egypt and Germany. Susan E. Conrad's co-authors include Moriko Ito, Christine Stewart, Shibani Mukherjee, Judith L. Campbell, Michael R. Botchan, Sandra Z. Haslam, Holger Roehl, Kathleen A. Gallo, Hemant Varma and Philip E. Stuart and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Susan E. Conrad

41 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan E. Conrad United States 26 934 521 345 131 121 41 1.4k
Joseph J. Lucas United States 27 983 1.1× 374 0.7× 243 0.7× 148 1.1× 59 0.5× 65 1.8k
Gustavo Leone United States 15 1.3k 1.4× 632 1.2× 203 0.6× 220 1.7× 71 0.6× 22 1.7k
Aya Leder United States 13 1.2k 1.3× 227 0.4× 373 1.1× 103 0.8× 210 1.7× 18 1.8k
Kerry Kelleher United States 18 831 0.9× 321 0.6× 131 0.4× 104 0.8× 78 0.6× 26 1.8k
John Wagner Canada 25 1.2k 1.3× 186 0.4× 184 0.5× 85 0.6× 195 1.6× 38 1.8k
Anne E. Milner United Kingdom 26 1.2k 1.3× 758 1.5× 204 0.6× 266 2.0× 86 0.7× 44 2.3k
Daniel S. Pereira Brazil 22 885 0.9× 440 0.8× 338 1.0× 166 1.3× 132 1.1× 76 1.7k
Michal Štros Czechia 21 1.3k 1.3× 302 0.6× 159 0.5× 157 1.2× 45 0.4× 36 1.9k
Hideo Yawata Japan 16 829 0.9× 1.1k 2.1× 199 0.6× 242 1.8× 73 0.6× 18 2.4k
H.‐G. Thiele Germany 23 545 0.6× 451 0.9× 226 0.7× 141 1.1× 28 0.2× 75 1.8k

Countries citing papers authored by Susan E. Conrad

Since Specialization
Citations

This map shows the geographic impact of Susan E. Conrad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan E. Conrad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan E. Conrad more than expected).

Fields of papers citing papers by Susan E. Conrad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan E. Conrad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan E. Conrad. The network helps show where Susan E. Conrad may publish in the future.

Co-authorship network of co-authors of Susan E. Conrad

This figure shows the co-authorship network connecting the top 25 collaborators of Susan E. Conrad. A scholar is included among the top collaborators of Susan E. Conrad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan E. Conrad. Susan E. Conrad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Misek, Sean A., Thomas S. Dexheimer, Susan E. Conrad, et al.. (2022). BRAF Inhibitor Resistance Confers Increased Sensitivity to Mitotic Inhibitors. Frontiers in Oncology. 12. 766794–766794. 4 indexed citations
3.
Gallo, Kathleen A., et al.. (2019). Therapeutic potential of targeting mixed lineage kinases in cancer and inflammation. Pharmacology & Therapeutics. 207. 107457–107457. 17 indexed citations
4.
Conrad, Susan E., et al.. (2017). MLK3 regulates FRA-1 and MMPs to drive invasion and transendothelial migration in triple-negative breast cancer cells. Oncogenesis. 6(6). e345–e345. 51 indexed citations
5.
Wang, Limin, et al.. (2012). The scaffold protein MEK Partner 1 is required for the survival of estrogen receptor positive breast cancer cells. Cell Communication and Signaling. 10(1). 18–18. 8 indexed citations
6.
Decker, Celeste, Zi‐Fan Yu, Roberto Giugliani, et al.. (2010). Enzyme replacement therapy for mucopolysaccharidosis VI: Growth and pubertal development in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase. Journal of Pediatric Rehabilitation Medicine. 3(2). 89–100. 52 indexed citations
7.
Aupperlee, Mark D., Jianwei Xie, Richard J. Miksicek, et al.. (2009). Progesterone receptor A-regulated gene expression in mammary organoid cultures. The Journal of Steroid Biochemistry and Molecular Biology. 115(3-5). 161–172. 29 indexed citations
8.
Haslam, Sandra Z., et al.. (2007). Estrogen and Progesterone are Critical Regulators of Stat5a Expression in the Mouse Mammary Gland. Endocrinology. 149(1). 329–338. 36 indexed citations
9.
Varma, Hemant, Andrew Skildum, & Susan E. Conrad. (2007). Functional Ablation of pRb Activates Cdk2 and Causes Antiestrogen Resistance in Human Breast Cancer Cells. PLoS ONE. 2(12). e1256–e1256. 26 indexed citations
10.
Mukherjee, Shibani & Susan E. Conrad. (2005). c-Myc Suppresses p21WAF1/CIP1 Expression during Estrogen Signaling and Antiestrogen Resistance in Human Breast Cancer Cells. Journal of Biological Chemistry. 280(18). 17617–17625. 96 indexed citations
11.
Zhang, Hua, Wei Wu, Yan Du, et al.. (2004). Hsp90/p50cdc37 Is Required for Mixed-lineage Kinase (MLK) 3 Signaling. Journal of Biological Chemistry. 279(19). 19457–19463. 49 indexed citations
12.
Skildum, Andrew, Shibani Mukherjee, & Susan E. Conrad. (2002). The Cyclin-dependent Kinase Inhibitor p21WAF1/Cip1 Is an Antiestrogen-regulated Inhibitor of Cdk4 in Human Breast Cancer Cells. Journal of Biological Chemistry. 277(7). 5145–5152. 30 indexed citations
13.
Shalhevet, D., et al.. (1993). Rapid communication: a MspI polymorphism at the porcine interleukin-6 (IL-6) locus. Journal of Animal Science. 71(12). 3478–3478. 1 indexed citations
14.
Dagher, Suzanne F., Susan E. Conrad, Elizabeth Werner, & Ronald J. Patterson. (1992). Phenotypic conversion of TK-deficient cells following electroporation of functional TK enzyme. Experimental Cell Research. 198(1). 36–42. 13 indexed citations
15.
Roehl, Holger & Susan E. Conrad. (1990). Identification of a G 1 -S-Phase-Regulated Region in the Human Thymidine Kinase Gene Promoter. Molecular and Cellular Biology. 10(7). 3834–3837. 9 indexed citations
16.
Stewart, Christine, Moriko Ito, & Susan E. Conrad. (1987). Evidence for Transcriptional and Post-Transcriptional Control of the Cellular Thymidine Kinase Gene. Molecular and Cellular Biology. 7(3). 1156–1163. 33 indexed citations
17.
Stuart, Philip E., Moriko Ito, Christine Stewart, & Susan E. Conrad. (1985). Induction of Cellular Thymidine Kinase Occurs at the mRNA Level. Molecular and Cellular Biology. 5(6). 1490–1497. 83 indexed citations
18.
Conrad, Susan E. & Michael R. Botchan. (1982). Isolation and Characterization of Human DNA Fragments with Nucleotide Sequence Homologies with the Simian Virus 40 Regulatory Region. Molecular and Cellular Biology. 2(8). 949–965. 28 indexed citations
19.
Conrad, Susan E. & Judith L. Campbell. (1979). Characterization of an improved in vitro DNA replication system for Escherichia coli plasmids. Nucleic Acids Research. 6(10). 3289–3304. 29 indexed citations
20.
Yen, Pauline H., Ann Sodja, Maurice Cohen, et al.. (1977). Sequence arrangement of tRNA genes on a fragment of drosophila melanogaster DNA cloned in E. coli. Cell. 11(4). 763–777. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joseph J. Lucas Breakdown of academic impact, for papers by Gustavo Leone Breakdown of academic impact, for papers by Aya Leder Breakdown of academic impact, for papers by Kerry Kelleher Breakdown of academic impact, for papers by John Wagner Breakdown of academic impact, for papers by Anne E. Milner Breakdown of academic impact, for papers by Daniel S. Pereira Breakdown of academic impact, for papers by Michal Štros Breakdown of academic impact, for papers by Hideo Yawata Breakdown of academic impact, for papers by H.‐G. Thiele
Rankless by CCL
2026